Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05296265 · ClinicalTrials.gov registry record · NA
Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain
A NA study, sponsored by Albert Einstein Healthcare Network.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT05296265 is a NA study that has completed, run by Albert Einstein Healthcare Network. The registered enrollment target is 46 participants.
The verdict
NCT05296265, a NA study, has completed, sponsored by Albert Einstein Healthcare Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
After amputation of an arm or leg, up to 90% of subjects experience a "phantom limb", a phenomenon characterized by persistent feelings of the missing limb. Many subjects with a phantom limb experience intense pain in the missing extremity that is often poorly responsive to medications or other interventions. The proposed work will contrast the efficacy of two virtual reality treatments for phantom limb pain: a 'Distractor' and an Active VR treatment. In the Distractor treatment, participants are engaged in a visually immersive virtual reality experience that does not require leg movements (REAL i-Series® immersive VR experience). In the Active VR treatment, subjects play a series of VR games using the virtual rendering of both legs.
Interventions
- BEHAVIORAL VR treatment for phantom limb pain
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2022-05-10 |
| Est. Completion | 2025-04-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05296265
The ClinicalTrials.gov registry entry for NCT05296265 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein Healthcare Network, which has 48 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which VR treatment for phantom limb pain is the first listed.
NCT05296265 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05296265 about?
NCT05296265 is a clinical study titled "Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain". After amputation of an arm or leg, up to 90% of subjects experience a "phantom limb", a phenomenon characterized by persistent feelings of the missing limb. Many subjects with a phantom limb experience intense pain in the missing extremity that is often poorly responsive to medications or other inte...
What is the current status of trial NCT05296265?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2022-05-10. Estimated completion is 2025-04-06.
What interventions are being tested in trial NCT05296265?
The interventions under investigation include: VR treatment for phantom limb pain (BEHAVIORAL).
Who is sponsoring clinical trial NCT05296265?
This trial is sponsored by Albert Einstein Healthcare Network, which has 48 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.